SG11202010623YA - Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof - Google Patents

Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof

Info

Publication number
SG11202010623YA
SG11202010623YA SG11202010623YA SG11202010623YA SG11202010623YA SG 11202010623Y A SG11202010623Y A SG 11202010623YA SG 11202010623Y A SG11202010623Y A SG 11202010623YA SG 11202010623Y A SG11202010623Y A SG 11202010623YA SG 11202010623Y A SG11202010623Y A SG 11202010623YA
Authority
SG
Singapore
Prior art keywords
potent
preparing
pharmaceutical formulation
thiazole compound
thiazole
Prior art date
Application number
SG11202010623YA
Inventor
Parul Ganju
Sudhanand Prasad
Mahesh Verma
Kashinath Komirishetty
Annie Richharia
Original Assignee
Ahammune Biosciences Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ahammune Biosciences Private Ltd filed Critical Ahammune Biosciences Private Ltd
Publication of SG11202010623YA publication Critical patent/SG11202010623YA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
SG11202010623YA 2018-04-27 2019-04-26 Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof SG11202010623YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201821015990 2018-04-27
PCT/IB2019/053459 WO2019207548A1 (en) 2018-04-27 2019-04-26 Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof

Publications (1)

Publication Number Publication Date
SG11202010623YA true SG11202010623YA (en) 2020-11-27

Family

ID=68294614

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202010623YA SG11202010623YA (en) 2018-04-27 2019-04-26 Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof

Country Status (10)

Country Link
US (1) US20210275502A1 (en)
EP (1) EP3799593A4 (en)
JP (1) JP2021522338A (en)
AU (1) AU2019260644B2 (en)
BR (1) BR112020022016A2 (en)
CA (1) CA3098522A1 (en)
IL (1) IL278322B2 (en)
MA (1) MA52979A (en)
SG (1) SG11202010623YA (en)
WO (1) WO2019207548A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (en) * 1965-10-07
JP2009531289A (en) * 2006-02-10 2009-09-03 ライフ テクノロジーズ コーポレーション Method for modifying and labeling proteins with oligosaccharides
EP2862856B1 (en) * 2012-06-15 2018-08-01 Mitsubishi Tanabe Pharma Corporation Imidazole and triazole compounds as dgat-1 inhibitors
WO2015172196A1 (en) * 2014-05-13 2015-11-19 Monash University Heterocyclic compounds and use of same

Also Published As

Publication number Publication date
AU2019260644A1 (en) 2020-12-17
CA3098522A1 (en) 2019-10-31
IL278322B1 (en) 2023-04-01
WO2019207548A1 (en) 2019-10-31
IL278322A (en) 2020-12-31
IL278322B2 (en) 2023-08-01
BR112020022016A2 (en) 2021-02-23
MA52979A (en) 2021-04-28
US20210275502A1 (en) 2021-09-09
AU2019260644B2 (en) 2024-02-22
EP3799593A4 (en) 2022-03-09
JP2021522338A (en) 2021-08-30
EP3799593A1 (en) 2021-04-07
WO2019207548A4 (en) 2019-12-19

Similar Documents

Publication Publication Date Title
ZA201808286B (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
ZA201804770B (en) New ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them
HUE049507T2 (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
EP3668479B8 (en) Process for preparing a powdered composition
ZA202001046B (en) Process for preparing a drug delivery composition
IL282218A (en) New amino-pyrimidonyl-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
EP3303320A4 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
EP3728280C0 (en) Method for improving the oral bioavailability of a drug
SG11202010623YA (en) Process for preparing a potent thiazole compound, pharmaceutical formulation and uses thereof
IL279873A (en) Amino-pyrimidonyl derivatives, a process for their preparation and pharmaceutical compositions containing them
GB201819292D0 (en) A process for preparing a formulation
EP3870149A4 (en) Decalin derivatives, a process for the preparation and pharmaceutical composition thereof
IL273553A (en) Method for preparing a pharmaceutical product
IL275381A (en) A process for the preparation of crisaborole
SG11202105807XA (en) Process for the preparation of a cyclic dinucleotide
PL3741744T3 (en) A pharmaceutical intermediate for preparing pimavanserin
EP3755701A4 (en) Antimalarial heterocyclic compounds and a process for the preparation thereof
EP3681880A4 (en) Process for preparing crystalline tipiracil hydrochloride
EP3273967A4 (en) A process for the preparation of lorcaserin hydrochloride
PL3725774T3 (en) Process for the preparation of a pharmaceutical agent
EP3592333A4 (en) A pharmaceutical composition comprising racecadotril and process for preparing the same
EP3471552A4 (en) Process for preparing a soluble protein composition
GB2564515B (en) Pharmaceutical composition and a method for manufacturing the same
SG10201912063PA (en) A pharmaceutical formulation
EP3463333A4 (en) A process for the preparation of eluxadoline